News tagged with hepatitis c virus
Related topics: hepatitis c , hepatitis , liver cancer , liver disease , virus
Researchers indentify a cell-permeable peptide that inhibits hepatitis C
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
Diseases, Conditions, Syndromes
Jan 31, 2012 |
not rated yet |
0
|
Entry point for hepatitis C infection identified
A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of ...
Diseases, Conditions, Syndromes
Jan 24, 2012 |
4.5 / 5 (2) |
0
|
Combination of oral drugs suppresses common type of hepatitis C
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Diseases, Conditions, Syndromes
Jan 19, 2012 |
not rated yet |
0
|
Scientists show brain vulnerable to Hepatitis C virus
(Medical Xpress) -- Scientists at the University of Birmingham have demonstrated for the first time that human brain cells can become infected with the Hepatitis C virus (HCV), it is reported today.
Diseases, Conditions, Syndromes
Jan 18, 2012 |
5 / 5 (3) |
0
Researchers identify potential new therapy approach for hepatitis C
Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases.
Diseases, Conditions, Syndromes
Jan 16, 2012 |
not rated yet |
0
|
New fibrosis classification improves accuracy of diagnosis in hepatitis C
A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January ...
Diseases, Conditions, Syndromes
Jan 10, 2012 |
not rated yet |
0
First trial of a new hepatitis C vaccine shows promise
(Medical Xpress) -- A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.
Diseases, Conditions, Syndromes
Jan 05, 2012 |
5 / 5 (4) |
0
|
Hepatitis C virus survives by hijacking liver microRNA: study
Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them ...
Diseases, Conditions, Syndromes
Jan 02, 2012 |
4.8 / 5 (4) |
0
|
Lipid-modifying enzyme: New target for pan-viral therapeutics
Three different disease-causing viruses -- poliovirus, coxsackievirus, and hepatitis C -- rely on their unwilling host for the membrane platforms enriched in a specific lipid, phosphatidylinositol 4 phosphate (PI4P) on which ...
Medical research
Dec 07, 2011 |
not rated yet |
0
University launches iphone app for hepatitis treatment
The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C (HCV) patients with quick and easy access to the latest information about drug interactions.
Diseases, Conditions, Syndromes
Nov 22, 2011 |
not rated yet |
0
Gilead buys US pharma rival Pharmasset
US biotech firm Gilead Sciences announced plans Monday to acquire rival Pharmasset, a group specializing in treatments for AIDS and hepatitis, for $11 billion.
Medications
Nov 21, 2011 |
3 / 5 (1) |
0
Experimental drug suppresses rebound of hepatitis C virus in liver transplant patients
A human monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) given to patients with chronic hepatitis C virus (HCV) infection undergoing liver transplantation significantly ...
Diseases, Conditions, Syndromes
Nov 07, 2011 |
not rated yet |
0
The economic cost of advanced liver disease
Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study.
Diseases, Conditions, Syndromes
Nov 07, 2011 |
not rated yet |
0
New research on improved treatment options and screening strategies for Hepatitis C
Studies reporting on the effectiveness of new therapies for chronic Hepatitis C virus are among the clinical science presented at the American College of Gastroenterology's 76th Annual Scientific Meeting, where investigators ...
Diseases, Conditions, Syndromes
Oct 31, 2011 |
not rated yet |
0
Researchers pilot new acute hepatitis C screening strategy for HIV-infected patients
Researchers at The Miriam Hospital demonstrated a practical strategy for regularly screening HIV-infected patients for acute hepatitis C virus infection (HCV), a "silent epidemic" that is rising undetected in this population ...
HIV & AIDS
Oct 18, 2011 |
not rated yet |
0
